Impact of dexamethasone on the incidence of ventilator-associated pneumonia and blood stream infections in COVID-19 patients requiring invasive mechanical ventilation: a multicenter retrospective study

BACKGROUND: Dexamethasone decreases mortality in patients with severe coronavirus disease 2019 (COVID-19) and has become the standard of care during the second wave of pandemic. Dexamethasone is an immunosuppressive treatment potentially increasing the risk of secondary hospital acquired infections...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Ann Intensive Care
Main Authors: Gragueb-Chatti, Ines, Lopez, Alexandre, Hamidi, Dany, Guervilly, Christophe, Loundou, Anderson, Daviet, Florence, Cassir, Nadim, Papazian, Laurent, Forel, Jean-Marie, Leone, Marc, Dellamonica, Jean, Hraiech, Sami
Formato: Artigo
Idioma:Inglês
Publicado em: Springer International Publishing 2021
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8165680/
https://ncbi.nlm.nih.gov/pubmed/34057642
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13613-021-00876-8
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados